AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Paul Saladino MD podcast
242. Debunking Cholesterol Myths: New Study Reveals Surprising Findings! With Dave Feldman
Dec 19, 2023
Dave Feldman, a researcher studying LDL and cardiovascular risk, joins Paul Saladino on the podcast. They discuss a recent study about LDL and cardiovascular risk, the response from the medical community, and the role of credentials in online discussions. They also explore the risks and benefits of lipid-lowering therapies like statins and the effects of ketogenic and low carb diets on LDL cholesterol levels.
01:13:58
Episode guests
AI Summary
Highlights
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- Lean individuals with elevated LDL and ApoB levels may not have the same risk of cardiovascular disease as the general population.
- FH and lean mass hyper-responders, both with high LDL, are not the same and have differences in macrophage function and genetics.
Deep dives
The Study on Lean Mass Hyper-responders
A study is conducted on a unique population of lean individuals with significantly elevated LDL and ApoB levels. The purpose of the study is to determine whether these individuals, who are metabolically healthy, have the same increased risk of cardiovascular disease and plaque formation as the general population.
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode